iron sucrose injection USP

Phase 3Small molecule

iron sucrose injection USP is one of 68 small molecule programs targeting Iron deficiency anemia. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Iron Deficiency AnemiaActive, not recruiting

AnemiaActive, not recruiting

Iron Deficiency AnemiaPhase 2

Active, not recruiting

AnemiaPhase 3

Active, not recruiting

Competition

Competitive Landscape

272 competitors in Anemia

#DrugCompanyPhaseTrials

Rituxan

Roche

Phase 3

2 2

Ultomiris

AstraZeneca

Phase 3

1 3

Feosol

AAuerbach Hematology Oncology Associates P C

Phase 3

9 4

Soliris

AstraZeneca

Phase 3

1 5

Cytoxan

BBaxter Healthcare Corporation

Phase 3

6 6

Vafseo

AAkebia Therapeutics

Phase 3

4 7

Omontys

Takeda

Phase 3

9 8

Campath

GGenzyme, a Sanofi Company

Phase 3

2 9

Alkeran

AApotex Inc.

Phase 3

1 10

Jesduvroq

GGlaxo Dba Glaxosmithkline

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Anemia2 trials

Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis

Completed·AAmerican Regent, Inc.·Phase 3·NCT00236964·96 enrolled

Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy

Completed·AAmerican Regent, Inc.·Phase 3·NCT00236951·224 enrolled

Total Knee Replacement1 trial

Perioperative Iron With Erythropoietin in Bilateral Total Knee Replacement Arthroplasty (TKRA)

Completed·SSeoul National University Bundang Hospital·N/A·NCT01012063·54 enrolled

Iron deficiency anemia1 trial

Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women

Completed·AAmerican Regent, Inc.·Phase 2·NCT01290315·49 enrolled

PrEP1 trial

Comparison Between Effects of Two Iron Preparations on Protein in the Urine

Completed·WWatson Pharmaceuticals·Phase 1·NCT00534144·74 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for iron sucrose injection USP. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — iron sucrose injection USP compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for iron sucrose injection USP. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Watson Pharmaceuticals company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: WWatson Pharmaceuticals

iron sucrose injection USP

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Anemia2 trials

Total Knee Replacement1 trial

Iron deficiency anemia1 trial

PrEP1 trial

References

Drug Info

Quick Facts

Related News